| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,549 |
5,883 |
$1.02M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,214 |
8,564 |
$833K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,592 |
2,911 |
$536K |
| 80053 |
Comprehensive metabolic panel |
10,551 |
9,487 |
$381K |
| 36415 |
Collection of venous blood by venipuncture |
26,900 |
22,996 |
$345K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,332 |
6,125 |
$310K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,036 |
11,538 |
$264K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,104 |
4,937 |
$191K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
755 |
668 |
$135K |
| 87400 |
|
5,235 |
2,867 |
$108K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
706 |
623 |
$69K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,478 |
1,411 |
$60K |
| 87276 |
|
1,484 |
1,417 |
$59K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,586 |
4,425 |
$49K |
| 87430 |
|
1,949 |
1,860 |
$45K |
| 80061 |
Lipid panel |
818 |
795 |
$36K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
760 |
649 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
780 |
734 |
$29K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
178 |
168 |
$28K |
| 72020 |
|
642 |
608 |
$26K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
877 |
837 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
677 |
652 |
$25K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
74 |
61 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
223 |
206 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
427 |
410 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
262 |
252 |
$12K |
| 87077 |
|
307 |
284 |
$11K |
| 81001 |
|
1,248 |
1,131 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
153 |
142 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
399 |
363 |
$9K |
| 80305 |
|
226 |
215 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
254 |
232 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
735 |
452 |
$8K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
261 |
243 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
228 |
198 |
$8K |
| 99152 |
|
117 |
111 |
$8K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
190 |
50 |
$7K |
| 82728 |
|
150 |
143 |
$7K |
| A0425 |
Ground mileage, per statute mile |
213 |
157 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
242 |
221 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
127 |
119 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
246 |
223 |
$6K |
| 85027 |
|
257 |
214 |
$6K |
| 84439 |
|
199 |
191 |
$5K |
| 84145 |
|
166 |
156 |
$5K |
| 84484 |
|
293 |
224 |
$5K |
| 86738 |
|
84 |
80 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
116 |
76 |
$4K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
74 |
50 |
$4K |
| 76000 |
|
107 |
96 |
$4K |
| 86141 |
|
184 |
174 |
$4K |
| 83690 |
|
172 |
153 |
$4K |
| 87581 |
|
85 |
85 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
629 |
324 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
15 |
13 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
67 |
62 |
$3K |
| 87081 |
|
135 |
129 |
$3K |
| 73630 |
|
34 |
27 |
$3K |
| 87420 |
|
114 |
107 |
$2K |
| 83605 |
|
96 |
82 |
$2K |
| 0240U |
|
14 |
13 |
$2K |
| 82150 |
|
73 |
65 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
52 |
42 |
$2K |
| 86140 |
|
80 |
72 |
$2K |
| 82746 |
|
39 |
39 |
$2K |
| 82553 |
|
44 |
38 |
$1K |
| 86803 |
|
26 |
26 |
$1K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
93 |
89 |
$1K |
| 82784 |
|
17 |
13 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
54 |
53 |
$1K |
| 87040 |
|
17 |
12 |
$1K |
| 85018 |
|
74 |
70 |
$980.61 |
| 82550 |
|
57 |
50 |
$925.56 |
| 87210 |
|
54 |
52 |
$732.40 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
26 |
24 |
$678.96 |
| 82785 |
|
15 |
12 |
$642.24 |
| 85610 |
|
42 |
38 |
$601.55 |
| 82607 |
|
13 |
13 |
$593.90 |
| 86756 |
|
13 |
12 |
$583.77 |
| 81025 |
|
17 |
14 |
$574.20 |
| 85379 |
|
20 |
13 |
$389.70 |
| 83550 |
|
15 |
15 |
$389.55 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
12 |
$300.04 |
| 85730 |
|
16 |
12 |
$287.40 |
| 83540 |
|
15 |
15 |
$170.86 |
| 81003 |
|
27 |
25 |
$154.21 |
| 11721 |
|
20 |
12 |
$14.47 |